Stage IIB Breast Cancer Clinical Trials
60 clinical trials for Stage IIB Breast Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) — RECRUITING · PHASE3
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer — RECRUITING · PHASE2
- Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy — RECRUITING · PHASE3
- Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE3
- Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca — ACTIVE_NOT_RECRUITING · PHASE2
- Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer — COMPLETED · PHASE2
- Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer — COMPLETED · PHASE2
- Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction — ACTIVE_NOT_RECRUITING · PHASE2
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
- Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — COMPLETED · PHASE3
- Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer — COMPLETED · PHASE2
- Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery — COMPLETED · PHASE2
- Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors — TERMINATED · NA
- Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer — COMPLETED · NA
- Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery — COMPLETED · PHASE2
- Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors — COMPLETED · NA
- Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer — TERMINATED · NA
- Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission — COMPLETED · PHASE1
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE1
- Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer — COMPLETED · PHASE1
- Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer — COMPLETED · NA
- Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer — COMPLETED · NA
- Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer — COMPLETED · NA
- Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery — COMPLETED · PHASE2
- Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer — COMPLETED · NA
- Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors — COMPLETED · NA
- Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy — COMPLETED · PHASE2
- S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) — COMPLETED · NA
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer — TERMINATED · PHASE1
- Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer — COMPLETED · NA
- Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer — COMPLETED
- Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) — OTHER · NA
- Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors — COMPLETED · NA
- Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors — COMPLETED · PHASE2
- Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy — COMPLETED · NA
- eHealth Weight Loss Program in African American Breast Cancer Survivors — COMPLETED · NA
- High-Intensity Interval Training for Stage I-III Breast Cancer Patients — TERMINATED · NA
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer — TERMINATED · PHASE1
- Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid — TERMINATED · NA
- Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity — COMPLETED · NA
- Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin — COMPLETED · NA
- Broccoli Sprout Extract in Treating Patients With Breast Cancer — COMPLETED · PHASE1
- Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer — WITHDRAWN · NA
- Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer — COMPLETED
- MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment — COMPLETED
- KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer — WITHDRAWN · NA
- FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer — COMPLETED · NA
Refine this search